Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
9.62
+0.10 (1.05%)
At close: Sep 29, 2025, 4:00 PM EDT
9.66
+0.04 (0.42%)
After-hours: Sep 29, 2025, 6:21 PM EDT
Viatris Market Cap
Viatris has a market cap or net worth of $11.22 billion as of September 29, 2025. Its market cap has decreased by -17.13% in one year.
Market Cap
11.22B
Enterprise Value
25.22B
1-Year Change
-17.13%
Ranking
Category
Stock Price
$9.62
Market Cap Chart
Since May 15, 1984, Viatris's market cap has increased from $146.99M to $11.22B, an increase of 7,530.33%. That is a compound annual growth rate of 11.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 11.10B | -25.31% |
| Dec 31, 2024 | 14.86B | 14.38% |
| Dec 29, 2023 | 12.99B | -3.74% |
| Dec 30, 2022 | 13.50B | -17.51% |
| Dec 31, 2021 | 16.36B | -27.24% |
| Dec 31, 2020 | 22.49B | 116.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |